All In Biotech

Drug Trial Radar · NCT03199885

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 190 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

190

Actual

Start

Apr 5, 2019

Primary completion

Apr 30, 2024

Study completion Apr 4, 2025

Sponsor

Sponsor type
NIH
Collaborators
NRG Oncology
First posted
Jun 27, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab is a form of "targeted therapy" because it works by attaching itself to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors. When trastuzumab attaches to HER2 receptors, the signals that tell the cells to grow are blocked and the cancer cell may be marked for destruction by the body's immune system. Monoclonal antibodies, such as pertuzumab, may interfere with the ability of cancer cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab may kill more tumor cells. \*NOTE: This study has a central confirmation step. The purpose of this step is to confirm by central testing that the patient's tumor has specific receptors. If the patient meets all the study requirements, the patient will join the study and begin therapy for breast cancer while the tumor is being tested.

Conditions

  • Metastatic Breast Adenocarcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Recurrent Breast Adenocarcinoma
  • Recurrent HER2-Positive Breast Carcinoma
  • Stage III Breast Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma

Interventions

  • AtezolizumabDrug

    Given IV

  • BiopsyProcedure

    Undergo biopsy

  • Bone ScanProcedure

    Undergo bone scan

  • Computed TomographyProcedure

    Undergo CT scan

  • DocetaxelDrug

    Given IV

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • PaclitaxelDrug

    Given IV

  • PertuzumabBiological

    Given IV

  • Placebo AdministrationOther

    Given IV

  • Quality-of-Life AssessmentOther

    Ancillary studies

  • TrastuzumabBiological

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS)Time frame: At the definitive analysis 2.5 years

Locations

673 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • Katmai Oncology Group

    Anchorage, Alaska

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • CTCA at Western Regional Medical Center

    Goodyear, Arizona

  • Banner-University Medical Center Phoenix

    Phoenix, Arizona

  • Banner Boswell Medical Center

    Sun City, Arizona

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas

  • Kaiser Permanente-Anaheim

    Anaheim, California

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California

  • Kaiser Permanente-Baldwin Park

    Baldwin Park, California

  • Kaiser Permanente-Bellflower

    Bellflower, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • UC Irvine Health Cancer Center-Newport

    Costa Mesa, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Kaiser Permanente Dublin

    Dublin, California

  • Kaiser Permanente-Fontana

    Fontana, California

  • Kaiser Permanente-Fremont

    Fremont, California

  • Palo Alto Medical Foundation-Fremont

    Fremont, California

  • Washington Hospital

    Fremont, California

  • Kaiser Permanente-Fresno

    Fresno, California

  • Kaiser Permanente - Harbor City

    Harbor City, California

  • Kaiser Permanente-Irvine

    Irvine, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Kaiser Permanente West Los Angeles

    Los Angeles, California

  • Memorial Medical Center

    Modesto, California

  • Kaiser Permanente-Modesto

    Modesto, California

  • Palo Alto Medical Foundation-Camino Division

    Mountain View, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Kaiser Permanente-Ontario

    Ontario, California

  • Saint Joseph Hospital - Orange

    Orange, California

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California

  • Desert Regional Medical Center

    Palm Springs, California

  • Palo Alto Medical Foundation Health Care

    Palo Alto, California

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California

  • Kaiser Permanente - Panorama City

    Panorama City, California

  • Kaiser Permanente-Richmond

    Richmond, California

  • Kaiser Permanente-Riverside

    Riverside, California

  • Kaiser Permanente-Roseville

    Roseville, California

  • Kaiser Permanente Downtown Commons

    Sacramento, California

Showing 40 of 673 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.